Cite
MLA Citation
A Ilias et al.. “P694 Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomes.” Journal of Crohn's and colitis, vol. 12, n.d., pp. S461–S462. http://access.bl.uk/ark:/81055/vdc_100095522341.0x000010